Valuation : Raia Drogasil S.A.

Market Cap 34.95B 6.82B 5.86B 5.51B 5.03B 9.41B 645B 9.45B 65.39B 25.27B 330B 25.6B 25.04B 1,052B P/E 2026 *
23.7x
P/E 2027 * 17.5x
Enterprise Value 43.24B 8.43B 7.25B 6.82B 6.23B 11.65B 798B 11.68B 80.88B 31.26B 408B 31.67B 30.98B 1,301B EV / Sales 2026 *
0.95x
EV / Sales 2027 * 0.84x
Free-Float
73.24%
Yield 2026 *
1.83%
Yield 2027 * 2.15%
1 day-1.38%
1 week+1.99%
Current month+1.99%
1 month-1.14%
3 months+14.49%
6 months-15.76%
Current year-14.75%
1 week 19.5
Extreme 19.5
20.73
1 month 16.93
Extreme 16.93
20.73
Current year 16.21
Extreme 16.21
27.42
1 year 16.21
Extreme 16.21
27.42
3 years 12.81
Extreme 12.813725
29.8
5 years 12.81
Extreme 12.813725
29.8
10 years 10.42
Extreme 10.418549
29.8
Manager TitleAgeSince
Chief Executive Officer 50 2024-12-31
Director of Finance/CFO 63 2013-04-28
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 50 2024-12-31
Director/Board Member - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
5/29/26 Others -91,227 0.0052% -
5/28/26 Others -352,797 0.0201%
5/27/26 Others 351,489 0.0201%
Change 5-day change 1-year change 3-year change Capi.($)
-1.38%+1.99%+17.52%-23.98% 6.82B
-0.80%-3.75%-3.53%+29.68% 1.37B
+0.18%-5.06%+8.15%+17.56% 552M
-0.32%-0.39%-7.80%+27.70% 68.64M
Average -0.58%-1.39%+3.58%+12.74% 2.2B
Weighted average by Cap. -1.18%+1.78%+13.46%-12.61%

Financials

2026 *2027 *
Net sales 45.45B 8.87B 7.62B 7.17B 6.55B 12.24B 838B 12.28B 85.03B 32.87B 429B 33.29B 32.57B 1,368B 52B 10.14B 8.72B 8.2B 7.49B 14.01B 959B 14.05B 97.28B 37.6B 491B 38.09B 37.26B 1,565B
Net income 1.5B 293M 252M 237M 216M 405M 27.72B 406M 2.81B 1.09B 14.2B 1.1B 1.08B 45.22B 2.02B 394M 339M 319M 291M 544M 37.26B 546M 3.78B 1.46B 19.08B 1.48B 1.45B 60.78B
Net Debt 8.28B 1.62B 1.39B 1.31B 1.19B 2.23B 153B 2.24B 15.49B 5.99B 78.24B 6.07B 5.93B 249B 8.97B 1.75B 1.51B 1.42B 1.29B 2.42B 166B 2.42B 16.79B 6.49B 84.76B 6.57B 6.43B 270B
Logo Raia Drogasil S.A.
Raia Drogasil S.A. specializes in the distribution of medicines, cosmetics and dermocosmetics, perfumery, personal care and beauty products. Net sales break down by family of products as follows: - branded pharmaceuticals (42%); - pharmaceutical additives (25.1%) ; - OTC products (21.3%); - generic pharmaceutical products (11.4%). At the end of 2020, its products were marketed through a network of 2,299 pharmacies under the Drogasil (1,304) and Raia (995) brands in Brazil.
Employees
75,594
Date Price Change Volume
26-09-04 R$19.99 -1.38% 4,581,700
26-09-03 R$20.27 +0.25% 5,006,000
26-09-02 R$20.22 +2.85% 8,450,500
26-09-01 R$19.66 +0.31% 6,615,500
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
19.99BRL
Average target price
25.25BRL
Spread / Average Target
+26.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RADL3 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!